Lichen sclerosus is a chronic skin condition that requires ongoing attention and care throughout a person’s life. Treatment focuses on controlling symptoms like itching and pain, preventing permanent scarring, and reducing the risk of complications that can affect intimate areas of the body and overall quality of life.

Managing a Long-Term Skin Condition

When someone receives a diagnosis of lichen sclerosus, they’re beginning a journey that will likely last many years. This condition doesn’t have a cure, but modern medicine offers ways to keep symptoms under control and prevent the condition from getting worse. The main goals of treatment are to ease discomfort, help the skin look and feel better, and stop scarring from happening. Without proper care, the affected skin can become tight and damaged, leading to problems with everyday activities like using the bathroom or being intimate with a partner.^[1]

The type and intensity of treatment depends on several factors. Doctors consider where the condition appears on the body, how severe the symptoms are, whether there’s already scarring, and how the patient responds to initial treatments. Most people with lichen sclerosus affecting their genital area need treatment even if they don’t have symptoms yet, because early intervention can prevent permanent changes to the skin’s structure. The approach is different for each person, and healthcare providers often adjust the treatment plan over time as the condition changes.^[8]

Because lichen sclerosus is a lifelong condition, people living with it need regular check-ups with their doctor. These visits help catch any changes early, including rare but serious complications like skin cancer in the affected areas. The risk of cancer is small, but it’s higher than in people without the condition, which is why ongoing monitoring matters so much.^[3]

Standard Treatment Approaches

The foundation of lichen sclerosus treatment involves strong prescription ointments that are applied directly to the affected skin. These medications are called topical corticosteroids, and they work by reducing inflammation deep within the skin layers. The inflammation is what causes the itching, pain, and other symptoms that make lichen sclerosus so uncomfortable.^[8]

The most commonly prescribed medication is clobetasol propionate ointment, which belongs to a category called very strong or ultra-potent steroids. When treatment begins, patients typically apply this ointment twice a day for about a month or longer, depending on how their skin responds. After the initial treatment period brings symptoms under control, the frequency usually decreases. Many people then use the ointment once daily for a few weeks, followed by application just two or three times per week as maintenance therapy to prevent symptoms from returning.^[8]

The amount of medication to apply matters. Doctors often recommend using a pea-sized amount, or what’s called a fingertip unit, for each application. This is enough to cover the affected area without using more than necessary. Many people find it helpful to apply the ointment at night before bed, so clothing and toilet paper don’t rub it off before it has time to work.^[13]

Treatment guidelines published by major medical organizations, including the British Association of Dermatologists and the European Academy of Dermatology and Venereology, all recommend topical corticosteroids as the first-line therapy for lichen sclerosus. These recommendations are based on studies showing that these medications effectively control symptoms and improve the appearance of affected skin in most patients.^[15]

For people who cannot use corticosteroids or whose condition doesn’t improve with them, doctors may suggest alternative medications. Calcineurin inhibitors like tacrolimus ointment work differently than steroids by suppressing specific parts of the immune response that contribute to inflammation. These medications can be helpful as a second-line treatment or for maintenance therapy once symptoms are under control.^[8]

If the skin has become very thick or developed hard plaques that don’t respond well to ointments alone, doctors might use intralesional corticosteroid injections. This involves injecting medication directly into the affected tissue using a very fine needle. The injection delivers medication deeper into the skin where topical treatments may not penetrate as effectively.^[12]

In cases where lichen sclerosus has caused severe scarring or structural changes, surgery may be necessary. For men, circumcision—removal of the foreskin—is often effective when the condition affects the penis and doesn’t respond to medication. This procedure can relieve symptoms and prevent further complications in many cases, though the condition can still come back after surgery.^[8]

For women experiencing significant scarring that has narrowed the vaginal opening or caused other structural problems, surgical procedures may help restore function and reduce pain. These surgeries are typically reserved for situations where medication hasn’t been enough and the scarring is causing serious difficulties with daily life or intimacy.^[3]

Regardless of which treatment is used, long-term follow-up is essential. Most guidelines recommend that people with genital lichen sclerosus see their healthcare provider at least once or twice a year, even if symptoms are well-controlled. These check-ups allow the doctor to examine the skin, adjust treatment if needed, and watch for any warning signs of more serious problems.^[14]

Emerging Therapies Being Studied in Clinical Trials

While topical corticosteroids remain the standard of care, researchers continue investigating new treatment options for lichen sclerosus. These studies aim to find therapies that might work better for people who don’t respond well to current treatments, or that might prevent the condition from progressing to cause permanent changes.

One area of research involves different forms of light therapy. For lichen sclerosus affecting skin outside the genital area, phototherapy using specific wavelengths of ultraviolet light has shown promise in some studies. This treatment exposes the affected skin to controlled amounts of therapeutic light, which can reduce inflammation and improve symptoms. For genital lichen sclerosus, researchers have explored photodynamic therapy, which combines a light-sensitive medication with special light to target diseased tissue. These approaches are still being studied and are typically only considered when other treatments haven’t worked.^[9]

Laser treatments represent another innovative approach being tested in clinical trials. Some studies have examined whether laser therapy can improve symptoms and skin appearance in people with genital lichen sclerosus. One trial compared dual laser treatment using two types of lasers together (neodymium-doped yttrium aluminum garnet laser combined with erbium-doped yttrium aluminum garnet laser) against topical steroid therapy. The laser treatment produced comparable improvements in symptoms and skin appearance, and many patients reported higher satisfaction with this approach. However, more research is needed to understand the long-term effects and determine which patients might benefit most from laser therapy.^[15]

Researchers are also investigating medications that affect the immune system in different ways than current treatments. Because lichen sclerosus is thought to involve the immune system mistakenly attacking the body’s own tissues, therapies that modify immune function could potentially help control the condition. Some clinical trials have looked at medications like methotrexate and mycophenolate, which are used to treat other autoimmune conditions. These drugs work by dampening specific parts of the immune response that contribute to inflammation and tissue damage.^[15]

Another medication being explored is hydroxychloroquine, which has anti-inflammatory and immune-modifying properties. Some specialists report good results using this drug as a maintenance therapy for patients who need long-term control of their lichen sclerosus. Clinical trials are working to better understand how effective these systemic medications are compared to topical treatments, and whether they can prevent the condition from getting worse over time.^[15]

Platelet-rich plasma therapy is a newer experimental approach that involves taking a small amount of the patient’s own blood, processing it to concentrate certain healing factors, and then injecting or applying these factors to the affected tissue. This therapy has been suggested as a potential option for lichen sclerosus affecting the penis or urethra when standard treatments haven’t been sufficient. The concentrated platelets release growth factors and other substances that might help the skin heal and regenerate, though research is still in early stages.^[15]

Oral medications called retinoids, which are related to vitamin A, have been tested in some patients with lichen sclerosus. These medications affect how skin cells grow and mature. While they may be useful in selected cases, particularly when the skin has become very thick, more research is needed to understand their role in treatment and which patients might benefit from them.^[9]

Clinical trials for lichen sclerosus take place in various locations around the world, including Europe, the United States, and other regions. People interested in participating in research studies typically need to meet specific criteria, such as having a confirmed diagnosis, being in a certain age range, or having tried and not responded to standard treatments. Those interested in clinical trials should discuss the options with their healthcare provider, who can help determine whether participating in research might be appropriate and can provide information about available studies.^[9]

Most experimental therapies are still in early phases of testing. Phase I trials focus primarily on safety, determining whether a new treatment causes unacceptable side effects and what doses can be used safely. Phase II trials begin to examine whether the treatment actually works to improve symptoms or other measures of disease activity. Phase III trials compare the new treatment directly against current standard therapies to see if it’s better, equivalent, or has advantages like fewer side effects or easier use. Many of the novel approaches for lichen sclerosus are currently in Phase II or early Phase III testing, meaning researchers are still gathering evidence about their effectiveness.^[9]

Most common treatment methods

• Topical Corticosteroids
  • Clobetasol propionate ointment applied twice daily initially, then reduced to twice weekly for maintenance
  • Halobetasol ointment as an alternative ultra-potent steroid option
  • Betamethasone valerate or triamcinolone acetonide for less severe areas or maintenance therapy
  • Treatment typically continues for months or years to prevent symptom recurrence
• Immunomodulatory Therapies
  • Tacrolimus ointment as an alternative when corticosteroids cannot be used
  • Pimecrolimus cream for maintenance therapy
  • These medications suppress specific immune responses that cause inflammation
• Surgical Interventions
  • Circumcision for men with penile lichen sclerosus not responding to medication
  • Surgical procedures to widen vaginal opening when severe scarring has occurred
  • Surgery to release clitoral adhesions when fusion has developed
  • Procedures are reserved for advanced cases causing functional impairment
• Supportive Care Measures
  • Regular application of emollient moisturizers to protect and soothe skin
  • Use of petroleum jelly or similar barrier creams
  • Gentle cleansing with soap substitutes rather than harsh products
  • Avoidance of irritants like perfumes, tight clothing, and scented products
• Experimental Therapies
  • Laser treatments using neodymium-doped or erbium-doped yttrium aluminum garnet lasers
  • Phototherapy with ultraviolet light for extragenital disease
  • Photodynamic therapy combining light-sensitive medications with therapeutic light
  • Systemic medications like methotrexate, mycophenolate, or hydroxychloroquine for severe or resistant cases
  • Platelet-rich plasma injections for penile and urethral involvement
  • Oral or topical retinoids in selected patients